SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing high volatility as traders react to conflicting reports regarding the status of the Strait of Hormuz and ongoing U.S.-Iran negotiations. The community is deeply divided between those betting on a rapid supply-driven price crash following potential de-escalation and those anticipating further spikes due to persistent geopolitical instability and tight energy inventories.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened activity and investor interest driven by persistent buyout rumors and significant trading volume, as the community debates whether the stock is undervalued given its product portfolio and cash position. Shareholders remain deeply divided, with some betting on a potential hostile takeover or acquisition while others express frustration over leadership and the stock's failure to maintain momentum.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing heightened volatility and a sharp pullback as investors weigh index rebalancing pressures and recent project delays against its long-term role as a key infrastructure provider for AI data centers. The community remains deeply divided, with some traders viewing the decline as a major buying opportunity while others express caution regarding the stock's valuation and the broader sustainability of the power-infrastructure trade.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest the announcement of a late July FDA Advisory Committee meeting for Deramiocel, alongside new five-year data highlighting the therapy's durability. While some community members express concern over the potential for added volatility or delays, the majority of the discussion remains bullish, focusing on the FDA's shift toward increased transparency and the company's strong clinical evidence as catalysts for an imminent approval.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and significant selling pressure, with community sentiment deeply polarized between investors viewing the recent decline as a forced liquidation event and those identifying a generational buying opportunity. The ongoing debate centers on the sustainability of Saylor's BTC-accumulation strategy, the burden of rising dividend obligations from preferred securities, and the stock's weakening correlation with Bitcoin price action.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the community reacts to a new distribution deal with NBCUniversal that restores key sports and entertainment channels ahead of the FIFA World Cup. While bulls view the partnership and market scale as a turnaround catalyst, skeptics remain focused on long-term stock performance and persistent volatility.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor reports of a potential Japanese delegation visiting Greenland to evaluate rare earth opportunities, fueling hopes for strategic partnerships that could bypass Chinese supply chains. While the community remains divided on the pace of project development and communication, many shareholders are highlighting the stock's long-term potential as a critical component of Western defense and industrial supply independence.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong operational fundamentals, such as expanded shipping agreements and infrastructure growth, against the persistent geopolitical instability in the Strait of Hormuz. While some community members remain focused on the potential for long-term cash flow from new contracts, active discussion is dominated by the volatility driven by conflicting headlines regarding U.S.-Iran diplomatic status and its subsequent impact on oil and gas supply chains.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as retail investors weigh the recent loss of a key Medicare reimbursement court case against the company's strong revenue growth and upcoming clinical milestones. The community is actively debating whether the stock is undervalued or if potential institutional sell-offs and the impact of competing therapies will continue to weigh on the share price in the near term.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call

Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call PR Newswire ORLANDO, Fla., June 18, 2026 ORLANDO, Fla., June 18, 2026 /PRNewswire/ -- Xenia Hotels...

Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026

Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026 Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026 PR Newswire ORLANDO, Fla., May 15, 2026 ORLANDO, Fla., May 15, 2026...

XHR Crosses Above Average Analyst Target

In recent trading, shares of Xenia Hotels & Resorts Inc (Symbol: XHR) have crossed above the average analyst 12-month target price of $16.40, changing hands for $16.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow...

Xenia Hotels & Resorts Q1 Earnings Call Highlights

Xenia Hotels & Resorts (NYSE:XHR) reported first-quarter 2026 results that management said exceeded expectations across key metrics, driven by strength in both group and transient demand particularly...

Xenia Hotels & Resorts (NYSE:XHR) Releases Earnings Results, Beats Estimates By $0.45 EPS

Xenia Hotels & Resorts (NYSE:XHR - Get Free Report) announced its earnings results on Friday. The real estate investment trust reported $0.63 EPS for the quarter, topping the consensus estimate of $0.18 by $0.45. Xenia Hotels & Resorts had a return on equity of 5.13% and a net margin of 5.85%.The...

Transcript: Xenia Hotels & Resorts Q1 2026 Earnings Conference Call

Xenia Hotels & Resorts (NYSE:XHR) Sets New 52-Week High After Better-Than-Expected Earnings

Xenia Hotels & Resorts (NYSE:XHR) Hits New 12-Month High After Earnings Beat...

Xenia Hotels & Resorts (NYSE:XHR) Updates FY 2026 Earnings Guidance

Xenia Hotels & Resorts (NYSE:XHR) updated its FY 2026 earnings guidance. The company provided EPS guidance of 1.860-2.020 for the period, compared to the consensus estimate of 1.640...

Xenia Hotels & Resorts Reports First Quarter 2026 Results

Xenia Hotels & Resorts Reports First Quarter 2026 Results Xenia Hotels & Resorts Reports First Quarter 2026 Results PR Newswire ORLANDO, Fla., May 1, 2026 ORLANDO, Fla., May 1, 2026 /PRNewswire...

M&T Bank Corp Takes $4.20 Million Position in Xenia Hotels & Resorts, Inc. $XHR

M&T Bank Corp bought a new stake in Xenia Hotels & Resorts, Inc. (NYSE:XHR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 296,760 shares of the real estate investment trust's stock...

Xenia Hotels & Resorts, Inc. is a real estate investment trust, which engages in the provision of investment in luxury and upper upscale hotels and resorts. It also owns a diversified portfolio of lodging properties operated by Marriott, Kimpton, Hyatt, Aston, Fairmong, and Loews. The company was founded in 2007 and is headquartered in Orlando, FL.

Xenia Hotels & Resorts Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.25	--	--	N/A
Q1 '26	$0.18	$0.21	16.67%	BEAT
Q4 '25	$0.04	$0.07	100.00%	BEAT
Q3 '25	-$0.16	-$0.14	12.50%	BEAT
Q2 '25	$0.30	$0.56	84.94%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

XHRXenia Hotels & Resorts Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest XHR News